Chemerin in Colorectal Cancer and Its Relationship With Diet Quality

NCT06018077 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2023-08-30

No results posted yet for this study

Summary

To investigate the relationship between serum chemerin levels of individuals with colorectal cancer and systematic inflammatory response parameters such as C-reactive protein(CRP) and albumin, and to investigate the relationship of these biomarkers with dietary inflammatory index, phytochemical, anthropometric measurements, and dietary inflammatory index, which is calculated with the data obtained from the 24-hour food consumption record and food consumption frequency questionnaire. The aim of this study is to examine the relationships between the index and dietary antioxidant capacity and to compare them with those of healthy individuals.

Conditions

Interventions

BEHAVIORAL

Dietary İntake, Biochemical parameters, Antropometric measuruments

Nutritional status of individuals will be evaluated with a 24-hour retrospective food consumption record and food consumption frequency questionnaire. After 8-12 hours of fasting, body composition analysis will be performed and within the scope of anthropometric measurements, body weight, height length, BMI measurements will be taken. Then, venous blood will be taken from the participants C-reactive protein (CRP), albumin and chemerin level will be analyzed.

Sponsors & Collaborators

  • Ankara City Hospital Bilkent

    collaborator OTHER
  • Hacettepe University

    lead OTHER

Principal Investigators

  • Semra Bakir Angay · Hacettepe University

  • Aylin Acikgoz Pinar · Hacettepe University

Eligibility

Min Age
19 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-15
Primary Completion
2024-06-15
Completion
2025-08-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06018077 on ClinicalTrials.gov